Bioxytran Inc
(BIXT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 15 | 3 | 4 | 5 | 35 |
| TOTAL | $15 | $3 | $4 | $5 | $35 |
| Non-Current Assets | |||||
| Intangibles | 142 | 144 | 132 | 134 | 124 |
| TOTAL | $142 | $144 | $132 | $134 | $124 |
| Total Assets | $156 | $148 | $136 | $139 | $159 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 50 | 38 | 48 | 48 | N/A |
| Accounts payable and accrued liabilities | 1,687 | 1,214 | 971 | 667 | 312 |
| Accrued Expenses | N/A | N/A | N/A | N/A | 123 |
| Other current liabilities | 519 | 726 | 1,020 | 411 | 50 |
| TOTAL | $3,061 | $2,783 | $2,844 | $1,931 | $1,244 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $3,061 | $2,783 | $2,844 | $1,931 | $1,244 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 99,104 | 88,992 | 88,992 | 88,882 | 85,783 |
| Common Shares | 89 | 89 | 89 | 87 | 82 |
| Retained earnings | -20,522 | -20,239 | -20,275 | -18,921 | -18,299 |
| Other shareholders' equity | 13 | 0 | 0 | 0 | 0 |
| TOTAL | $-2,905 | $-2,635 | $-2,708 | $-1,792 | $-1,085 |
| Total Liabilities And Equity | $156 | $148 | $136 | $139 | $159 |